2017 Medicines in Development for Mental Illnesses

A quick read up and video about Vanderbiit’s and Astrazeneca’s m4 drug partnership, seems like there mainly doing it for Alzheimer’s.

Its fairly old 2014 so i dont know if there still in partnership now.

https://www.astrazeneca.com/what-science-can-do/labtalk-blog/collaboration/accelerating-drug-discovery-for-brain-disorders-a-partnership-model20141208.html#!

1 Like

Cognitive meds would be nice. Something along the lines of increasing delayed gratification and planning. I read that delaying gratification is very important in success.

There’s more recent news, from this year. But in the past they have pulled back compounds from pharma companies because they didn’t persue them.

1 Like

Good to know, thanks.

2 Likes